东曜药业股份有限公司（股票代码：01875）于2026年11月3日披露截至2026年10月31日的股份变动月报。报告期内，公司普通股已发行股份总数为772,787,887股，库存股份数量始终为0，与上月底保持一致。
公告显示，当月无新增股份发行、购回或注销活动，股本结构未发生变化。公司现有首发前购股权计划合计20,000份，与上月底持平，本月无期权行使、授出或失效事项。公司在月报中确认，截至报告期末，其公众持股量符合上市规则的最低要求。
公司强调已遵守香港联交所《上市规则》及相关法律法规，相关月报由其联席公司秘书吕颖一签署。据本次披露，公司的股本在10月保持稳定，暂无新增变化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.